Article Information
History
- January 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Rosica Valcheva1,2,
- Heather Armstrong3,
- Ognjen Kovic1,2,
- Michael Bording-Jorgensen1,4,
- Simona Veniamin1,2,
- María Elisa Pérez-Muñoz5,
- Natasha Haskey6,
- Melissa Silva1,2,
- Farhad Peerani2,
- Karen Wong2,
- Dina H. Kao1,2,
- Sander Veldhuyzen Van Zanten1,2,
- Karen I. Kroeker1,2,
- Deanna L. Gibson6,
- Eytan Wine1,4,
- Michael Gänzle5,
- Jens Walter6 and
- Levinus A. Dieleman1,2,*
- 1Centre of Excellence for Gastrointestinal Inflammation and Immunity Research, University of Alberta, Edmonton, AB, T6G 2X8, Canada
- 2Department of Medicine, University of Alberta, Edmonton, AB, T6G 1C9, Canada
- 3Department of Internal Medicine, University of Manitoba, Winnipeg, MB, R3E 3P4, Canada
- 4Department of Pediatrics, University of Alberta, Edmonton, AB, T6G 1C9, Canada
- 5Department of Agriculture, Food and Nutritional Sciences, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada
- 6Department of Biology, University of British Columbia, Kelowna, British Columbia, V1V 1V7, Canada
- 7APC Microbiome Ireland, School of Microbiology, and Department of Medicine, University College Cork, Cork, T12 YT20, Ireland
- ↵*Correspondence: Levinus (Leo) A. Dieleman, MD PhD, AGAF, Professor of Medicine, Co-Director of the Inflammatory Bowel Disease Unit, Director of Translational IBD Research, Dept. of Medicine, Division of Gastroenterology, Zeidler Bldg 2-24, 130 University Campus, Edmonton, T6G 2X8, Canada, l.dieleman{at}ualberta.ca, Tel: 780-492-8691 Ext 2 Fax:780-492-8121
Posted January 18, 2022.
Double blind placebo-controlled trial for the prevention of ulcerative colitis relapses by β-fructan prebiotics: efficacy and metabolomic analysis
